Close [X]
Companies & Industry »Company News»Company News Details
Company News Details

BSE   23 Feb 17 | 12:00 AM

430.05 -4.5 (-1.04%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: 532321
Face Value: N.A.

NSE   23 Feb 17 | 12:00 AM

430.70 -3.5 (-0.81%)
Mkt Price (Rs)   Chg Rs (Chg %)
Code: CADILAHC
Performance
1 Week : Rs 447.80 (-3.96%)
1 Month : Rs 357.75 (20.21%)
1 Year : Rs 326.25 (31.82%)
change companytradenow
Back

Cadila's stock rising: Credit Suisse

Reuters / 18 Jul 12 | 11:50 AM

Credit Suisse initiates coverage on Cadila Healthcare with an "outperform" rating and a target price of Rs 970.

Investment bank says the midcap drug maker has demonstrated "strong execution" in the United States, with a portfolio mix focusing on low competition products such as nasal sprays and injectable drugs.

Widgets Magazine

USFDA approval of its facilities in Moraiya, part of Gujarat, will re-start new approvals of its drugs in the US market, Credit Suisse adds.

"Cadila is moving up the value-chain with the launch of difficult-to formulate products and its strong execution record provides multi-year growth visibility."

Widgets Magazine

Sensex

Company Price Gain (%)
TCS2,481.652.99
Wipro485.552.53
Infosys1,009.051.73
Bharti Airtel366.051.36
ITC265.700.83

Online Portfolio

You can create Online Portfolio here using the below button.

Widgets Magazine